Stock Earnings

Question 1

What are Sarepta Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Sarepta Therapeutics Inc has a total asset of $3,349, Net loss of $-713

Question 2

What are the key financial ratios for SRPT?

Accepted Answer

Sarepta Therapeutics Inc's Current ratio is 1.51, has a Net margin is -32.43, sales per share of $21.95.

Question 3

How is Sarepta Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Sarepta Therapeutics Inc data is not available.

Question 4

Is Sarepta Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Sarepta Therapeutics Inc has a net loss of $-713

Question 5

Does Sarepta Therapeutics Inc have any liabilities?

Accepted Answer

yes, Sarepta Therapeutics Inc has liability of 2,209

Question 6

How many outstanding shares for Sarepta Therapeutics Inc?

Accepted Answer

Sarepta Therapeutics Inc has a total outstanding shares of 104.96

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	2,198	2,198	1,901	1,243	933	701
Revenue Growth (YoY)	16%	16%	53%	33%	33%	30%
Cost of Revenue	674	674	319	150	140	97
Gross Profit	1,523	1,523	1,582	1,092	793	604
Selling, General & Admin	491	491	557	481	451	282
Research & Development	1,522	1,522	804	877	877	771
Operating Expenses	2,016	2,016	1,364	1,360	1,329	1,054
Other Non Operating Income (Expenses)	3	3	38	50	4	0
Pretax Income	-702	-702	260	-520	-690	-418
Income Tax Expense	11	11	25	15	13	0
Net Income	-713	-713	235	-535	-703	-418
Net Income Growth	-403%	-403%	-144%	-24%	68%	-25%
Shares Outstanding (Diluted)	104.84	100.12	107.87	92.39	87.6	81.3
Shares Change (YoY)	-21%	-7%	17%	5%	8%	4%
EPS (Diluted)	-6.8	-7.12	2.18	-5.8	-8.03	-5.15
EPS Growth	-484%	-426.99%	-138%	-28%	56%	-28%
Free Cash Flow	-315	-315	-352	-588	-358	-485
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	69.29%	69.29%	83.21%	87.85%	84.99%	86.16%
Operating Margin	-22.38%	-22.38%	11.46%	-21.48%	-57.44%	-64.05%
Profit Margin	-32.43%	-32.43%	12.36%	-43.04%	-75.34%	-59.62%
Free Cash Flow Margin	-14.33%	-14.33%	-18.51%	-47.3%	-38.37%	-69.18%
EBITDA	-490	-490	220	-266	-536	-449
EBITDA Margin	-22.29%	-22.29%	11.57%	-21.39%	-57.44%	-64.05%
D&A For EBITDA	2	2	2	1	0	0
EBIT	-492	-492	218	-267	-536	-449
EBIT Margin	-22.38%	-22.38%	11.46%	-21.48%	-57.44%	-64.05%
Effective Tax Rate	-1.56%	-1.56%	9.61%	-2.88%	-1.88%	0%

Sarepta Therapeutics Inc (SRPT) Financial